184 related articles for article (PubMed ID: 22632378)
1. Impact of the bowel-screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran.
Roxburgh CS; McTaggart F; Balsitis M; Diament RH
Colorectal Dis; 2013 Jan; 15(1):34-41. PubMed ID: 22632378
[TBL] [Abstract][Full Text] [Related]
2. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site.
Steele RJ; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser CG
Gut; 2012 Apr; 61(4):576-81. PubMed ID: 21930729
[TBL] [Abstract][Full Text] [Related]
3. Improved 5-year survival of patients with immunochemical faecal blood test-screen-detected colorectal cancer versus non-screening cancers in northern Italy.
Parente F; Vailati C; Boemo C; Bonoldi E; Ardizzoia A; Ilardo A; Tortorella F; Cereda D; Cremaschini M; Moretti R
Dig Liver Dis; 2015 Jan; 47(1):68-72. PubMed ID: 25306524
[TBL] [Abstract][Full Text] [Related]
4. Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer.
Steele RJ; McClements PL; Libby G; Carey FA; Fraser CG
Colorectal Dis; 2014 Jan; 16(1):28-32. PubMed ID: 24034143
[TBL] [Abstract][Full Text] [Related]
5. Symptoms do not predict colorectal cancer in an FOB screened population.
Saldanha JD; Moug SJ; Linton K; Diament RH
Scott Med J; 2013 May; 58(2):95-8. PubMed ID: 23728754
[TBL] [Abstract][Full Text] [Related]
6. Screen-detected colorectal cancers show improved cancer-specific survival when compared with cancers diagnosed via the 2-week suspected colorectal cancer referral guidelines.
Courtney ED; Chong D; Tighe R; Easterbrook JR; Stebbings WS; Hernon J
Colorectal Dis; 2013 Feb; 15(2):177-82. PubMed ID: 22709315
[TBL] [Abstract][Full Text] [Related]
7. Impact of the Scottish Bowel Cancer Screening Programme on patient and tumour characteristics at a single centre.
Mackay C; Ramsay G; Rafferty A; Loudon M
J Eval Clin Pract; 2014 Feb; 20(1):7-11. PubMed ID: 23890078
[TBL] [Abstract][Full Text] [Related]
8. A comparison of tumour and host prognostic factors in screen-detected vs nonscreen-detected colorectal cancer: a contemporaneous study.
Mansouri D; McMillan DC; McIlveen E; Crighton EM; Morrison DS; Horgan PG
Colorectal Dis; 2016 Oct; 18(10):967-975. PubMed ID: 26859503
[TBL] [Abstract][Full Text] [Related]
9. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
10. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
11. Local impact of the English arm of the UK Bowel Cancer Screening Pilot study.
Goodyear SJ; Stallard N; Gaunt A; Parker R; Williams N; Wong L
Br J Surg; 2008 Sep; 95(9):1172-9. PubMed ID: 18690636
[TBL] [Abstract][Full Text] [Related]
12. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
[TBL] [Abstract][Full Text] [Related]
13. The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire.
Goodyear SJ; Leung E; Menon A; Pedamallu S; Williams N; Wong LS
Gut; 2008 Feb; 57(2):218-22. PubMed ID: 18048571
[TBL] [Abstract][Full Text] [Related]
14. Urgency of referral and its impact on outcome in patients with colorectal cancer.
Ramsay G; MacKay C; Nanthakumaran S; Craig WL; McAdam TK; Loudon MA
Colorectal Dis; 2012 Jul; 14(7):e375-7. PubMed ID: 22284530
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of the '2-week wait' referral service for colorectal cancer.
Leung E; Grainger J; Bandla N; Wong L
Int J Clin Pract; 2010 Nov; 64(12):1671-4. PubMed ID: 20946272
[TBL] [Abstract][Full Text] [Related]
16. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
17. Does the location of colorectal carcinoma differ between screened and unscreened populations?
Mackay CD; Ramsay G; Rafferty A; Loudon MA
Colorectal Dis; 2012 Oct; 14(10):e689-91. PubMed ID: 22726268
[TBL] [Abstract][Full Text] [Related]
18. Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre.
Ellul P; Fogden E; Simpson CL; Nickerson CL; McKaig BC; Swarbrick ET; Veitch AM
Colorectal Dis; 2010 May; 12(5):420-2. PubMed ID: 19843116
[TBL] [Abstract][Full Text] [Related]
19. Temporal trends in mode, site and stage of presentation with the introduction of colorectal cancer screening: a decade of experience from the West of Scotland.
Mansouri D; McMillan DC; Crearie C; Morrison DS; Crighton EM; Horgan PG
Br J Cancer; 2015 Jul; 113(3):556-61. PubMed ID: 26158422
[TBL] [Abstract][Full Text] [Related]
20. Analysis of colorectal cancer stage among HMO members targeted for screening.
Myers RE; Murray J; Weinberg D; McGrory G; Wolf T; Caveny J; Hanchak N; Schlackman N; Comis R
Arch Intern Med; 1997 Sep; 157(17):2001-6. PubMed ID: 9308512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
